Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma, Open-Angle | 12 | 2022 | 706 | 1.060 |
Why?
|
Optic Disk | 7 | 2022 | 400 | 0.940 |
Why?
|
Intraocular Pressure | 9 | 2022 | 1270 | 0.440 |
Why?
|
Nails | 3 | 2018 | 292 | 0.380 |
Why?
|
Cataract Extraction | 4 | 2019 | 481 | 0.370 |
Why?
|
Visual Fields | 8 | 2022 | 1047 | 0.350 |
Why?
|
Optic Nerve Diseases | 2 | 2020 | 327 | 0.260 |
Why?
|
Phacoemulsification | 2 | 2019 | 149 | 0.250 |
Why?
|
Exfoliation Syndrome | 2 | 2017 | 110 | 0.250 |
Why?
|
Bruch Membrane | 3 | 2019 | 64 | 0.230 |
Why?
|
Tomography, Optical Coherence | 6 | 2022 | 2657 | 0.210 |
Why?
|
Lens Implantation, Intraocular | 2 | 2014 | 192 | 0.210 |
Why?
|
Ophthalmology | 2 | 2018 | 508 | 0.190 |
Why?
|
Capillaries | 3 | 2021 | 773 | 0.190 |
Why?
|
Visual Acuity | 5 | 2020 | 2530 | 0.180 |
Why?
|
Retinal Detachment | 2 | 2023 | 411 | 0.170 |
Why?
|
Retinal Vessels | 3 | 2020 | 772 | 0.160 |
Why?
|
Retinal Diseases | 1 | 2023 | 683 | 0.140 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2017 | 189 | 0.130 |
Why?
|
Accommodation, Ocular | 1 | 2014 | 48 | 0.130 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1525 | 0.120 |
Why?
|
Depth Perception | 1 | 2014 | 94 | 0.120 |
Why?
|
Pseudophakia | 1 | 2013 | 62 | 0.120 |
Why?
|
Microscopic Angioscopy | 3 | 2018 | 22 | 0.110 |
Why?
|
Postoperative Care | 1 | 2019 | 1486 | 0.110 |
Why?
|
Refraction, Ocular | 1 | 2013 | 182 | 0.110 |
Why?
|
Artificial Organs | 1 | 2014 | 204 | 0.110 |
Why?
|
Microcirculation | 1 | 2017 | 1286 | 0.100 |
Why?
|
Tonometry, Ocular | 3 | 2019 | 237 | 0.100 |
Why?
|
Microvessels | 3 | 2021 | 544 | 0.100 |
Why?
|
Clinical Competence | 2 | 2018 | 4687 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1198 | 0.100 |
Why?
|
Visual Field Tests | 3 | 2019 | 383 | 0.100 |
Why?
|
Retinal Ganglion Cells | 3 | 2022 | 770 | 0.100 |
Why?
|
Sebaceous Gland Diseases | 1 | 2010 | 5 | 0.090 |
Why?
|
Eyelashes | 1 | 1990 | 16 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2015 | 454 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1060 | 0.090 |
Why?
|
Hair Diseases | 1 | 1990 | 74 | 0.090 |
Why?
|
Eyelid Diseases | 1 | 2010 | 155 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2022 | 25043 | 0.080 |
Why?
|
Corneal Diseases | 1 | 2014 | 636 | 0.080 |
Why?
|
Caffeine | 1 | 2012 | 699 | 0.080 |
Why?
|
Coffee | 1 | 2012 | 578 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2014 | 1387 | 0.070 |
Why?
|
Cornea | 1 | 2014 | 1524 | 0.070 |
Why?
|
Nerve Fibers | 2 | 2020 | 687 | 0.070 |
Why?
|
Corneal Transplantation | 1 | 1990 | 386 | 0.070 |
Why?
|
Curriculum | 1 | 2018 | 3605 | 0.060 |
Why?
|
Cysts | 1 | 2010 | 678 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4042 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2291 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2012 | 1148 | 0.060 |
Why?
|
Aged | 15 | 2020 | 163280 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 185 | 0.050 |
Why?
|
Aged, 80 and over | 9 | 2019 | 57776 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2020 | 21746 | 0.050 |
Why?
|
Scotoma | 1 | 2022 | 139 | 0.050 |
Why?
|
Blood Pressure | 2 | 2018 | 8554 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4091 | 0.050 |
Why?
|
Internship and Residency | 2 | 2018 | 5788 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2014 | 4234 | 0.050 |
Why?
|
Middle Aged | 13 | 2020 | 213383 | 0.040 |
Why?
|
Female | 18 | 2022 | 380194 | 0.040 |
Why?
|
Benchmarking | 2 | 2016 | 1042 | 0.040 |
Why?
|
Male | 16 | 2022 | 350118 | 0.040 |
Why?
|
Angiography | 1 | 2022 | 1639 | 0.040 |
Why?
|
Humans | 22 | 2023 | 744343 | 0.040 |
Why?
|
Prospective Studies | 5 | 2020 | 53288 | 0.040 |
Why?
|
Graft Rejection | 1 | 1990 | 4397 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2017 | 245 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2020 | 77449 | 0.030 |
Why?
|
Regression Analysis | 2 | 2016 | 6459 | 0.030 |
Why?
|
Fluorescein Angiography | 1 | 2019 | 940 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2309 | 0.030 |
Why?
|
Massachusetts | 2 | 2018 | 8663 | 0.030 |
Why?
|
Acid-Base Equilibrium | 1 | 2014 | 185 | 0.030 |
Why?
|
Refractive Errors | 1 | 2014 | 142 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.030 |
Why?
|
Leisure Activities | 1 | 2014 | 311 | 0.030 |
Why?
|
Sunlight | 1 | 2014 | 325 | 0.030 |
Why?
|
Occupations | 1 | 2014 | 517 | 0.030 |
Why?
|
Gonioscopy | 1 | 2012 | 157 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 549 | 0.030 |
Why?
|
Israel | 1 | 2014 | 796 | 0.030 |
Why?
|
Lenses, Intraocular | 1 | 2013 | 140 | 0.030 |
Why?
|
Ocular Hypertension | 1 | 2012 | 198 | 0.020 |
Why?
|
Adult | 9 | 2018 | 214055 | 0.020 |
Why?
|
Video Recording | 1 | 2015 | 949 | 0.020 |
Why?
|
Muramidase | 1 | 2010 | 174 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1336 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1179 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 294 | 0.020 |
Why?
|
Keratins | 1 | 2010 | 515 | 0.020 |
Why?
|
Postoperative Period | 1 | 2013 | 1842 | 0.020 |
Why?
|
Cataract | 1 | 2014 | 834 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 644 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2029 | 0.020 |
Why?
|
Beverages | 1 | 2012 | 820 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6365 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2019 | 15295 | 0.020 |
Why?
|
Prognosis | 2 | 2017 | 29063 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2014 | 2050 | 0.020 |
Why?
|
Chronic Disease | 1 | 2017 | 9146 | 0.010 |
Why?
|
Eye Abnormalities | 1 | 1984 | 246 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
Optic Nerve | 1 | 1984 | 554 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 20947 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4026 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12026 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Recurrence | 1 | 1990 | 8340 | 0.010 |
Why?
|
Risk Factors | 1 | 2014 | 72290 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 63114 | 0.000 |
Why?
|
United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
Coloboma | 1 | 1984 | 54 | 0.000 |
Why?
|
Electroretinography | 1 | 1984 | 509 | 0.000 |
Why?
|
Amblyopia | 1 | 1984 | 143 | 0.000 |
Why?
|
Evoked Potentials, Visual | 1 | 1984 | 427 | 0.000 |
Why?
|
Ultrasonography | 1 | 1984 | 5985 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1984 | 25625 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1984 | 39050 | 0.000 |
Why?
|
Infant | 1 | 1984 | 35136 | 0.000 |
Why?
|
Child, Preschool | 1 | 1984 | 41006 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1984 | 20129 | 0.000 |
Why?
|
Child | 1 | 1984 | 77709 | 0.000 |
Why?
|
Adolescent | 1 | 1984 | 85781 | 0.000 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_